Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
Dr. Susan Love discusses her partnership with the Avon Foundation and the origins of the “Army of Women” fighting to prevent and cure breast cancer. References and Resources…
NEW YORK (Reuters Health) – High-dose therapy (HDT) combined with autologous stem cell transplantation (ASCT) may prolong remissions and improve survival in patients with chemoresistant Hodgkin lymphoma, researchers…
NEW YORK (Reuters Health) – In evaluating screening mammograms for breast cancer, a single reader with computer assistance can perform just as well as two readers, the results…
NEW YORK (Reuters Health) – The results of a new study indicate that 80% of cancer patients undergoing radiation therapy do not use medications to combat pain. Many…
NEW YORK (Reuters Health) – While raloxifene and tamoxifen are broadly similar in reducing breast cancer risk, raloxifene appears also to lower the odds of developing endometrial cancer,…
NEW YORK (Reuters Health) – The risk of lung cancer is increased in patients with rheumatoid arthritis, even after taking into account the effects of tobacco and asbestos…
NEW YORK (Reuters Health) – If an initial screening colonoscopy indicates no colorectal neoplasia, the odds that a malignancy will develop in the next 5 years is “extremely…
NEW YORK (Reuters Health) – For patients with radiation or chemical cystitis refractory to standard therapy, submucosal injection of botulinum toxin A (BoNT-A) into the bladder wall appears…
NEW YORK (Reuters Health) – New research indicates that overweight patients with operable breast cancer are less likely than their normal weight peers to achieve a complete pathologic…
NEW YORK (Reuters Health) – New research indicates that many older patients who survive colorectal cancer do not receive guideline-recommended follow-up with office visits, carcinoembryonic antigen (CEA) testing,…
